PSMA-Specific CAR-Engineered T Cells for Prostate Cancer: CD28 Outperforms Combined CD28-4-1BB “Super-Stimulation”

Overview of attention for article published in Frontiers in oncology, September 2021

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (64th percentile)
High Attention Score compared to outputs of the same age and source (89th percentile)

So far, Altmetric has seen 7 X posts from 7 X users, with an upper bound of 12,661 followers.

RT @CARTTherapy: PSMA-Specific CAR-Engineered T Cells for Prostate Cancer: CD28 Outperforms Combined CD28-4-1BB “Super-Stimulation” https:/…

PSMA-Specific CAR-Engineered T Cells for Prostate Cancer: CD28 Outperforms Combined CD28-4-1BB “Super-Stimulation” https://t.co/KGlLRFQWq5 #CART #bmtsm #CARTcell #immunotherapy #tcellrx #ICAN #CRS #CARTcells #CellTherapy @FrontImmunol

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 3 additional X posts.